Related Experiment Video
Updated: Sep 10, 2025
Studies of Chaperone-Cochaperone Interactions using Homogenous Bead-Based Assay
Published on: July 21, 2021
Design of multi-target peptide modulators for protein chaperone networks
Luca Torielli1, Matteo Castelli1, Francesca Milani1
1Department of Chemistry, University of Pavia, Via Taramelli 12, 27100 Pavia, Italy.
Abstract:
Essential chaperones heat shock protein 70 (Hsp70) and heat shock protein 90 (Hsp90) collaborate in oncoprotein folding. Dual inhibition of these chaperones has shown synergy in preclinical studies but remains challenging to achieve. Using a computational approach, we designed peptides mimicking the predicted unfolding regions of Kinase CDK4, a client protein of both Hsp70 and Hsp90. Peptide Cdk4-2 is shown to simultaneously bind Hsp70, Hsp90, and co-chaperone Cdc37. Cdk4-2 is membrane permeable, inhibits CDK4-mediated retinoblastoma phosphorylation, and induces apoptosis in renal carcinoma cells. Structure-function studies identified a minimal pharmacophore for Hsp70 binding and critical interactions for peptide affinity. These findings demonstrate the feasibility of rationally designing multi-target modulators of chaperone networks. Cdk4-2 is a promising lead for therapeutic development, expanding the molecular space of modulators of cancer-associated multiprotein machineries. While focused on chaperones, the idea behind our strategy is general and immediately transferable to other multiprotein targets and networks.
Insights
Researchers designed a novel peptide, Cdk4-2, that simultaneously targets key cancer-associated proteins heat shock protein 70 (Hsp70) and heat shock protein 90 (Hsp90). This peptide shows promise for cancer therapy by inhibiting tumor growth and inducing cell death.
Area of Science:
- Molecular Biology
- Drug Discovery
- Cancer Research
Background:
- Heat shock proteins (Hsp70 and Hsp90) are crucial for cancer oncoprotein folding.
- Dual inhibition of these chaperones offers synergistic therapeutic potential but is difficult to achieve.
- Targeting chaperone networks presents a novel strategy for cancer treatment.
Purpose of the Study:
- To computationally design peptides that mimic unfolding regions of CDK4, a client protein of Hsp70 and Hsp90.
- To develop a multi-target modulator for inhibiting chaperone networks involved in cancer.
- To evaluate the therapeutic potential of designed peptides in renal carcinoma cells.
Main Methods:
- Computational peptide design based on predicted protein unfolding regions.
- In silico screening and structure-function studies for peptide-target interactions.
- In vitro assays to assess peptide membrane permeability, enzyme inhibition, and apoptosis induction.
Main Results:
- Peptide Cdk4-2 was designed to bind Hsp70, Hsp90, and Cdc37 simultaneously.
- Cdk4-2 demonstrated membrane permeability and inhibited CDK4-mediated retinoblastoma phosphorylation.
- The peptide induced apoptosis in renal carcinoma cells, showing therapeutic efficacy.
- Structure-function analysis identified key binding interactions and a minimal pharmacophore for Hsp70.
Conclusions:
- Rational design of multi-target modulators for chaperone networks is feasible.
- Cdk4-2 is a promising therapeutic lead for cancer treatment, targeting multiple proteins.
- The strategy is transferable to other multiprotein targets and networks beyond chaperones.
Related Concept Videos
03:00Molecular Chaperones and Protein Folding
The...
01:26Bacterial Protein Maturation
02:04Protein-protein Interfaces
01:39Mitochondrial Precursor Proteins
Most of the mitochondrial...
02:26Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
01:58Cooperative Allosteric Transitions